Jens Benn Sørensen

Jens Benn Sørensen

Clinical Associate Professor

Member of:

  • Clinical Oncology


Publication year:
All
51 - 60 out of 106Page size: 10
  1. 2013
  2. Published

    Platinum-based doublet chemotherapy plus bevacizumab without bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC)

    Nørøxe, D. S., Wallerek, S. & Sørensen, Jens Benn, 2013, In: Anticancer Research. 33, 8, p. 3275-3278 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase III trial

    Vilmar, A. C., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2013, In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 24, 2, p. 309-14 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    RRM1 protein expression heterogeneity between diagnostic biopsies and resection specimens and changes in expression during carboplatin and paclitaxel treatment in non-small cell lung cancer

    Jakobsen, J., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2013, In: European Journal of Cancer.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. 2012
  6. Published

    A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma

    Zimling, Z. G., Sørensen, Jens Benn, Gerds, Thomas Alexander, Bech, C., Andersen, C. B. & Santoni Rugiu, Eric, Nov 2012, In: Cancer Chemotherapy and Pharmacology. 70, 5, p. 743-54 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity

    Jensen, S. A. & Sørensen, Jens Benn, 2012, In: Cancer Chemotherapy and Pharmacology. 69, 1, p. 57-64 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant plural mesothelioma

    Zimling, Z. G., Sørensen, Jens Benn, Gerds, Thomas Alexander, Bech, C., Andersen, C. B. & Santoni-Rugiu, E., 2012, In: Cancer Chemotherapy and Pharmacology. 70, 5, p. 743-754 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?

    Andersen, M., Grauslund, M., Muhammad-Ali, M., Ravn, J., Sørensen, Jens Benn, Andersen, C. B. & Santoni Rugiu, Eric, 2012, In: A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 120, 9, p. 767-9 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Carcinoembryonic antigen (CEA) as tumor marker in lung cancer

    Knudsen, M. G. & Sørensen, Jens Benn, 2012, In: Lung Cancer. 76, 2, p. 138-43 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer

    Jakobsen, J. N. & Sørensen, Jens Benn, 2012, In: Cancer Chemotherapy and Pharmacology. 69, 2, p. 289-99 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival

    Zimling, Z. G., Sørensen, Jens Benn, Gerds, Thomas Alexander, Bech, C., Andersen, C. B. & Santoni Rugiu, Eric, 2012, In: Journal of Thoracic Oncology. 7, 1, p. 249-56 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 12 3 4 5 6 7 8 9 ...11 Next

ID: 34406177